The genetic diagnostics market is expected to reach $15.3 billion by 2027 at a CAGR of 7.65 percent. This growth is driven by the rapidly growing genetics technology domain. Today, even the slightest modification to an inherited condition in genes can be identified through genetic testing.
For instance, predictive genetic tests are bringing substantial benefits to health outcomes by using blood, hair, skin, or other tissue samples from a person to help predict future risk of disease. The potential is enormous, as these tests can identify mutations that increase a person’s risk of developing genetic disorders before symptoms appear. If a medical intervention or preventive measures exist for a predicted disease, then the power of such digital tools becomes extremely useful and even lifesaving.
To put the spotlight on such key developments in the industry, Healthcare Tech Outlook APAC illustrates how the genetic diagnostics space is leveraging data for innovations and design interventions. This edition also features thought leadership articles from subject matter experts. Some of the exclusive insights are authored by Derya DİLEK KANÇAĞI, PhD, Laboratory Manager at Acıbadem Labcell Cellular Therapy Center, Acibadem Healthcare Group; Karen Dale, Chief Diversity, Equity, and Inclusion Officer at AmeriHealth Caritas Family of Companies; and Roberta Harbison, Corporate Director of Sterilization, HLD, Endoscopy, and Surgical Service line at AtlantiCare. They shed light on immunotherapy methods involving CAR T cells, the right time in health care to align people, policies, and structures in a culturally responsive way, and backstage caregivers in the healthcare industry.
In this edition of Healthcare Tech Outlook APAC, we also bring to you the story of the top genetic diagnostics solution providers in APAC leveraging noninvasive prenatal testing (NIPT) services to hospitals. In the list, DNA Advanced Medicine stands out for its NIPT testing for medical facilities in Japan. Its services include contracts with laboratories, supply of materials, and logistics of samples.
Through the following pages, we aim to shine a light on the innovative trends and latest developments in the genetic diagnostics industry. We would like to know your thoughts.
